Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
about
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@en
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@nl
type
label
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@en
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@nl
prefLabel
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@en
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@nl
P2093
P2860
P1476
Heat-induced BRCA2 degradation ...... hibitor combination therapies.
@en
P2093
Agnes Jager
Anja Raams
Berina Eppink
Dik C van Gent
Dineke H P M Smedts
Gerard C van Rhoon
Gerda M Verduijn
Hanny Odijk
Helena C van Doorn
Jan C Drooger
P2860
P356
10.1080/02656736.2017.1355487
P577
2017-07-13T00:00:00Z